ZA200603810B - Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents
Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- ZA200603810B ZA200603810B ZA200603810A ZA200603810A ZA200603810B ZA 200603810 B ZA200603810 B ZA 200603810B ZA 200603810 A ZA200603810 A ZA 200603810A ZA 200603810 A ZA200603810 A ZA 200603810A ZA 200603810 B ZA200603810 B ZA 200603810B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- phenylpyridylpiperazine
- compounds
- Prior art date
Links
- JLECMXGHGHVRFB-UHFFFAOYSA-N 2-phenyl-1-pyridin-2-ylpiperazine Chemical class C1NCCN(C=2N=CC=CC=2)C1C1=CC=CC=C1 JLECMXGHGHVRFB-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Psychology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0504758A FR2885616B1 (fr) | 2005-05-12 | 2005-05-12 | Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200603810B true ZA200603810B (en) | 2007-08-29 |
Family
ID=35668833
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200603810A ZA200603810B (en) | 2005-05-12 | 2006-05-12 | Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them |
Country Status (25)
Country | Link |
---|---|
US (1) | US7494994B2 (no) |
EP (1) | EP1721897A1 (no) |
JP (1) | JP2006316061A (no) |
KR (1) | KR100807481B1 (no) |
CN (1) | CN100569767C (no) |
AP (1) | AP2007004223A0 (no) |
AR (1) | AR054121A1 (no) |
AU (1) | AU2006201994A1 (no) |
BR (1) | BRPI0601773A (no) |
CA (1) | CA2546392A1 (no) |
CR (1) | CR9499A (no) |
EA (1) | EA011155B1 (no) |
FR (1) | FR2885616B1 (no) |
GE (1) | GEP20084470B (no) |
GT (1) | GT200700097A (no) |
IL (1) | IL186862A0 (no) |
MA (1) | MA28326A1 (no) |
MY (1) | MY141784A (no) |
NO (1) | NO20062083L (no) |
NZ (1) | NZ547122A (no) |
SG (1) | SG127801A1 (no) |
TN (1) | TNSN07395A1 (no) |
UA (1) | UA87284C2 (no) |
WO (1) | WO2006120349A1 (no) |
ZA (1) | ZA200603810B (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030236259A1 (en) * | 2002-02-05 | 2003-12-25 | Rolf Hohlweg | Novel aryl- and heteroarylpiperazines |
ATE536344T1 (de) * | 2005-07-04 | 2011-12-15 | High Point Pharmaceuticals Llc | Histamine h3 receptor antagonisten |
PL2079732T3 (pl) | 2006-05-29 | 2012-05-31 | High Point Pharmaceuticals Llc | 3-(1,3-benzodioksol-5-ylo)-6-(4-cyklopropylopiperazyn-1-ylo)-pirydazyna, jej sole i solwaty oraz jej zastosowanie jako antagonisty receptora histaminowego h3 |
ES2620818T3 (es) * | 2006-12-14 | 2017-06-29 | Janssen Pharmaceutica N.V. | Procedimiento para la preparación de derivados de piperazinil y diazepanil benzamida |
EP2014656A3 (en) | 2007-06-11 | 2011-08-24 | High Point Pharmaceuticals, LLC | New heteocyclic h3 antagonists |
MX343788B (es) | 2011-02-23 | 2016-11-23 | Lupin Ltd | Derivados de heteroarilo como moduladores de nachr alfa 7. |
NZ629453A (en) | 2012-03-06 | 2016-04-29 | Lupin Ltd | Thiazole derivatives as alpha 7 nachr modulators |
WO2017083216A1 (en) * | 2015-11-12 | 2017-05-18 | Merck Sharp & Dohme Corp. | Cyanopyridine derivatives as liver x receptor beta agonists, compositions, and their use |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0361489A3 (en) * | 1988-09-30 | 1991-06-12 | Chugai Seiyaku Kabushiki Kaisha | Novel 3,4-diaminoquinoline and pyridine compounds |
JPH06501019A (ja) * | 1990-09-13 | 1994-01-27 | スミスクライン・ビーチャム・コーポレイション | ピリジルチオまたはピリジルオキシアルカン酸 |
JP2001502307A (ja) * | 1996-10-04 | 2001-02-20 | ノボ ノルディスク アクティーゼルスカブ | 1,4―ジ置換ピペラジン |
DE69839887D1 (de) * | 1997-10-02 | 2008-09-25 | Eisai R&D Man Co Ltd | Kondensierte pyridinderivate |
BR9813279B1 (pt) * | 1997-10-27 | 2010-11-16 | derivado de homopiperazina, composição farmacêutica, e, uso do derivado de homopiperazina. | |
GB9919776D0 (en) * | 1998-08-31 | 1999-10-27 | Zeneca Ltd | Compoujnds |
US20030236259A1 (en) * | 2002-02-05 | 2003-12-25 | Rolf Hohlweg | Novel aryl- and heteroarylpiperazines |
-
2005
- 2005-05-12 FR FR0504758A patent/FR2885616B1/fr not_active Expired - Fee Related
-
2006
- 2006-05-02 MA MA28997A patent/MA28326A1/fr unknown
- 2006-05-05 SG SG200603045A patent/SG127801A1/en unknown
- 2006-05-09 NO NO20062083A patent/NO20062083L/no not_active Application Discontinuation
- 2006-05-10 MY MYPI20062154A patent/MY141784A/en unknown
- 2006-05-11 UA UAA200605182A patent/UA87284C2/ru unknown
- 2006-05-11 US US11/432,250 patent/US7494994B2/en not_active Expired - Fee Related
- 2006-05-11 EP EP06290758A patent/EP1721897A1/fr not_active Withdrawn
- 2006-05-11 NZ NZ547122A patent/NZ547122A/en unknown
- 2006-05-11 WO PCT/FR2006/001050 patent/WO2006120349A1/fr active Application Filing
- 2006-05-11 AP AP2007004223A patent/AP2007004223A0/xx unknown
- 2006-05-11 GE GEAP20069393A patent/GEP20084470B/en unknown
- 2006-05-11 AR ARP060101889A patent/AR054121A1/es unknown
- 2006-05-12 JP JP2006133322A patent/JP2006316061A/ja active Pending
- 2006-05-12 EA EA200600760A patent/EA011155B1/ru not_active IP Right Cessation
- 2006-05-12 CN CNB2006101263989A patent/CN100569767C/zh not_active Expired - Fee Related
- 2006-05-12 ZA ZA200603810A patent/ZA200603810B/xx unknown
- 2006-05-12 KR KR1020060042839A patent/KR100807481B1/ko not_active IP Right Cessation
- 2006-05-12 AU AU2006201994A patent/AU2006201994A1/en not_active Abandoned
- 2006-05-12 BR BRPI0601773-8A patent/BRPI0601773A/pt not_active IP Right Cessation
- 2006-05-12 CA CA002546392A patent/CA2546392A1/fr not_active Abandoned
-
2007
- 2007-10-23 IL IL186862A patent/IL186862A0/en unknown
- 2007-10-24 TN TNP2007000395A patent/TNSN07395A1/en unknown
- 2007-11-05 CR CR9499A patent/CR9499A/es not_active Application Discontinuation
- 2007-11-07 GT GT200700097A patent/GT200700097A/es unknown
Also Published As
Publication number | Publication date |
---|---|
SG127801A1 (en) | 2006-12-29 |
KR100807481B1 (ko) | 2008-02-25 |
WO2006120349A1 (fr) | 2006-11-16 |
FR2885616A1 (fr) | 2006-11-17 |
IL186862A0 (en) | 2008-02-09 |
CA2546392A1 (fr) | 2006-11-12 |
US20060258670A1 (en) | 2006-11-16 |
GEP20084470B (en) | 2008-08-25 |
US7494994B2 (en) | 2009-02-24 |
BRPI0601773A (pt) | 2007-05-15 |
EP1721897A1 (fr) | 2006-11-15 |
KR20060117263A (ko) | 2006-11-16 |
AR054121A1 (es) | 2007-06-06 |
EA011155B1 (ru) | 2009-02-27 |
NZ547122A (en) | 2007-05-31 |
JP2006316061A (ja) | 2006-11-24 |
MY141784A (en) | 2010-06-30 |
AP2007004223A0 (en) | 2007-10-31 |
CN100569767C (zh) | 2009-12-16 |
NO20062083L (no) | 2006-11-13 |
CN1896073A (zh) | 2007-01-17 |
CR9499A (es) | 2008-02-20 |
EA200600760A1 (ru) | 2006-12-29 |
UA87284C2 (ru) | 2009-07-10 |
MA28326A1 (fr) | 2006-12-01 |
FR2885616B1 (fr) | 2007-06-22 |
AU2006201994A1 (en) | 2006-11-30 |
TNSN07395A1 (en) | 2009-03-17 |
GT200700097A (es) | 2009-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200704957B (en) | Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them | |
SG131857A1 (en) | δD-CRYSTALLINE FORM OF IV ABRADINE HYDROCHLORIDE, A PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | |
AP2384A (en) | 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them. | |
IL178544A0 (en) | ??-crystalline form of ivabradine hydrochlorioe, a process for its preparation and pharmaceutical compositions containing it | |
EP1871363A4 (en) | COMBINED STAGE PROCESS FOR PHARMACEUTICAL COMPOSITIONS | |
IL184562A (en) | Polymorph ivandront a, a process for its preparation and pharmaceutical preparations containing it | |
LT1729739T (lt) | Kietos farmacinės kompozicijos gamybos būdas | |
HK1096386A1 (en) | Indanyl-piperazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
ZA200801991B (en) | Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds | |
ZA200801103B (en) | Tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them | |
ZA200603810B (en) | Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
SG121999A1 (en) | New benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
HK1096097A1 (en) | Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
HK1093986A1 (en) | Piperazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
HK1126190A1 (en) | Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them | |
ZA200704955B (en) | Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them | |
ZA200800833B (en) | New 1H-indole-pyridinecarboxamide and 1H-indolepiperidinecarboxamide compounds, a process for their preparation and pharmaceutical compositions containing them | |
ZA200606276B (en) | Polysubstituted 1,1-pyridylaminocyclopropanamine compounds, a process for their preparation and pharmaceutical compositions containing them | |
ZA200606277B (en) | Polysubstituted 1,1-pyridyloxycyclopropanamine compounds, a process for their preparation and pharmaceutical compositions containing them | |
ZA200704956B (en) | Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them | |
SG110170A1 (en) | New benzoindoline compounds, a process for their preparation and pharmaceutical compositions containing them | |
SG122000A1 (en) | New benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
HK1123048A1 (en) | Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds | |
ZA200708215B (en) | Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them |